Legato Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-339,501
| Closed | -$4.19M | – | 639 |
|
|
2024
Q4 | $4.19M | Hold |
339,501
| – | – | 0.55% | 21 |
|
|
2024
Q3 | $3.86M | Buy |
339,501
+83,020
| +32% | +$833K | 0.48% | 31 |
|
|
2024
Q2 | $1.83M | Hold |
256,481
| – | – | 0.25% | 134 |
|
|
2024
Q1 | $1.72M | Buy |
256,481
+36,809
| +17% | +$253K | 0.21% | 152 |
|
|
2023
Q4 | $1.43M | Hold |
219,672
| – | – | 0.19% | 171 |
|
|
2023
Q3 | $2.07M | Sell |
219,672
-56,137
| -20% | -$676K | 0.3% | 90 |
|
|
2023
Q2 | $3.85M | Buy |
275,809
+237,809
| +626% | +$4.05M | 0.52% | 37 |
|
|
2023
Q1 | $713K | Sell |
38,000
-19,520
| -34% | -$321K | 0.13% | 265 |
|
|
2022
Q4 | $792K | Sell |
57,520
-170,649
| -75% | -$2.61M | 0.15% | 234 |
|
|
2022
Q3 | $4.36M | Sell |
228,169
-53,710
| -19% | -$979K | 1.13% | 12 |
|
|
2022
Q2 | $4.3M | Buy |
281,879
+50,835
| +22% | +$752K | 0.96% | 20 |
|
|
2022
Q1 | $4.71M | Hold |
231,044
| – | – | 0.96% | 37 |
|
|
2021
Q4 | $6.74M | Sell |
231,044
-74,070
| -24% | -$2.12M | 1.25% | 27 |
|
|
2021
Q3 | $6.58M | Sell |
305,114
-34,976
| -10% | -$844K | 1.25% | 24 |
|
|
2021
Q2 | $8.72M | Sell |
340,090
-12,754
| -4% | -$272K | 1.23% | 17 |
|
|
2021
Q1 | $6.43M | Sell |
352,844
-62,620
| -15% | -$1.04M | 1.21% | 22 |
|
|
2020
Q4 | $4.79M | Sell |
415,464
-44,704
| -10% | -$409K | 0.91% | 34 |
|
|
2020
Q3 | $3.51M | Buy |
460,168
+47,139
| +11% | +$357K | 0.77% | 40 |
|
|
2020
Q2 | $2.71M | Hold |
413,029
| – | – | 0.55% | 35 |
|
|
2020
Q1 | $2.11M | Sell |
413,029
-6,449
| -2% | -$39K | 0.62% | 36 |
|
|
2019
Q4 | $3.22M | Hold |
419,478
| – | – | 0.67% | 33 |
|
|
2019
Q3 | $2.11M | Hold |
419,478
| – | – | 0.39% | 76 |
|
|
2019
Q2 | $2.35M | Buy |
419,478
+23,655
| +6% | +$97.5K | 0.43% | 70 |
|
|
2019
Q1 | $1.68M | Buy |
395,823
+158,003
| +66% | +$645K | 0.56% | 67 |
|
|
2018
Q4 | $975K | Buy |
+237,820
| New | +$1.24M | 0.2% | 114 |
|
Other funds holding CDMO
Legato Capital Management's CDMO Position: Q1 2025 in Review
Legato Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 339,501 shares — an estimated $4.19M sold.
Legato Capital Management first reported a position in CDMO in Q4 2018 and held it in 25 quarters. The position peaked at $8.72M in Q2 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Legato Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Legato Capital Management sold 339,501 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $4.19M.
- Legato Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 25 quarters.
- Legato Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $8.72M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Legato Capital Management's 13F filing for Q1 2025, filed 6 May 2025.